WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02269 WUXI BIO

Not Yet Opened 01-15 16:08:10

40.020

+0.020

+0.05%

High40.400	Low39.380	Vol30.01M
Open39.780	D1 Closing40.000	Amplitude2.55%
Mkt Cap165.44B	Tradable Cap165.44B	Total Shares4.13B
T/O1.20B	T/O Rate0.73%	Tradable Shares4.13B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"WUXI BIO","latestPrice":40.02,"timestamp":1768464490005,"preClose":40,"halted":0,"volume":30013466,"delay":0,"floatShares":4134000000,"shares":4134000000,"eps":0.9208337789526216,"marketStatus":"Not Yet Opened","change":0.02,"latestTime":"01-15 16:08:10","open":39.78,"high":40.4,"low":39.38,"amount":1199861368,"amplitude":0.0255,"askPrice":40.02,"askSize":82500,"bidPrice":40,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":1.1071048598920807,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1768527000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":40,"openAndCloseTimeList":[[1768440600000,1768449600000],[1768453200000,1768464000000]],"volumeRatio":0.610419,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.5264,"impliedVolPercentile":0.2683},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"2603622754","title":"WuXi XDC Launches Takeover Offer for BioDlink International, Forecasts Rise in 2025 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2603622754","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603622754?lang=en_us&edition=fundamental","pubTime":"2026-01-15 11:21","pubTimestamp":1768447295,"startTime":"0","endTime":"0","summary":"WuXi XDC (HKG:2268) made an offer to acquire BioDlink International (HKG:1875) for HK$4 per share in cash, according to a joint statement Wednesday.Shares of the contract research, development and man","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0516422366.SGD","LU2039709279.SGD","BK1161","LU0823426480.USD","IE00B0JY6N72.USD","02269","LU0326950275.SGD","LU0823426308.USD","LU0417516902.SGD","SG9999002463.SGD","LU0052750758.USD","BK1589","02268","LU0708995583.HKD","SG9999002562.SGD","LU0043850808.USD","LU0516422440.USD","LU0039217434.USD","BK1576","LU0348825331.USD","LU0417516738.SGD","BK1521","LU0516423091.SGD","LU0359202008.SGD","BK1574","BK1610","LU1720050803.USD","LU1880383366.USD","LU3063872942.SGD","LU0979878070.USD","SG9999014674.SGD","LU0051755006.USD","LU0359201612.USD","LU0572944931.SGD","LU1688375341.USD","LU1794554557.SGD","LU2488822045.USD","LU0140636845.USD","LU0456846285.SGD","LU0819121731.USD","LU0516423174.USD","LU0307460666.USD","LU0516422952.EUR","LU1242518931.SGD","01875","LU0456827905.SGD","BK1141","LU0856984785.SGD","LU0588546209.SGD","LU0320764599.SGD"],"gpt_icon":0},{"id":"1180094678","title":"Strong Growth Validated Again: Bispecific/Multispecific Molecules Emerge as New Engine for WUXI BIO's (02269) Non-Linear Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1180094678","media":"Stock News","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180094678?lang=en_us&edition=fundamental","pubTime":"2026-01-15 09:01","pubTimestamp":1768438891,"startTime":"0","endTime":"0","summary":"In 2025, driven by a bull market in innovative drugs, the Hang Seng Healthcare Index ultimately achieved an impressive annual gain of 56.95%. However, during this market trend driven by fluctuations...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU1794554557.SGD","LU0052750758.USD","LU0516423091.SGD","LU0456846285.SGD","LU1720050803.USD","LU2039709279.SGD","LU0856984785.SGD","LU0588546209.SGD","SG9999002562.SGD","LU0181495838.USD","BK1589","LU0359202008.SGD","LU0417516738.SGD","LU0043850808.USD","LU0979878070.USD","LU0039217434.USD","LU1242518931.SGD","LU0516422366.SGD","LU3063872942.SGD","LU0417516902.SGD","02269","LU0051755006.USD","LU0572944931.SGD","LU0348735423.USD","LU1880383366.USD","BK1141","BK1610","LU0708995583.HKD","LU0819121731.USD","LU0359201612.USD","LU0516422440.USD","BK1576","LU0823426480.USD","IE00B0JY6N72.USD","LU0348825331.USD","LU0456827905.SGD","LU0140636845.USD","LU0516422952.EUR","SG9999002463.SGD","LU0327786744.USD","LU1242518857.USD","LU1688375341.USD","LU0516423174.USD","LU0823426308.USD","LU0320764599.SGD","BK1521","LU0307460666.USD"],"gpt_icon":0},{"id":"1161056463","title":"Zhutong Hong Kong Stock Morning Briefing | Ministry of Finance Holds Meeting on Fiscal-Financial Synergy to Boost Domestic Demand; White House Announces 25% Tariff Hike on Specific Semiconductors","url":"https://stock-news.laohu8.com/highlight/detail?id=1161056463","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161056463?lang=en_us&edition=fundamental","pubTime":"2026-01-15 07:55","pubTimestamp":1768434913,"startTime":"0","endTime":"0","summary":"On the afternoon of January 13th, the Ministry of Finance, in conjunction with relevant departments, convened a nationwide video conference to advance the package of policies aimed at promoting...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1610","BK1615","09961","BK1516","BK1589","SOXX","SMH","LU1720050803.USD","BK1502","BK4588","300759","01875","BK1521","BK1564","WXXWY","BK1571","BK1147","BK1617","BK4585","03759","LU1794554557.SGD","BK1501","TCOM","BK1142","BK1515","BK1189","BK1584","02268","02269","BK1591","09688","BK1247","ZLAB"],"gpt_icon":1},{"id":"2603617138","title":"BioDlink International Says WuXi XDC Cayman To Make Conditional Cash Offer For All Co Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603617138","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603617138?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:11","pubTimestamp":1768403515,"startTime":"0","endTime":"0","summary":"Jan 14 (Reuters) - BioDlink International Co Ltd <1875.HK>::*CITI TO MAKE VOLUNTARY CONDITIONAL CASH OFFER FOR ALL ISSUED SHARES*OFFER PRICE OF HK$4.00/ OFFER SHARE*OFFER FOR ALL ISSUED SHARES OF CO O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nRSD96SvDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423174.USD","LU1688375341.USD","BK1589","LU0477156953.USD","LU0140636845.USD","LU0327786744.USD","LU0130517989.USD","LU0170899867.USD","BK4207","SG9999002562.SGD","LU0106831901.USD","LU1244550577.SGD","LU0039217434.USD","LU0516423091.SGD","LU2236285917.USD","LU2125154935.USD","LU1267930227.SGD","LU0348825331.USD","LU0456846285.SGD","LU2488822045.USD","LU1242518931.SGD","LU0980610538.SGD","LU0162691827.USD","02268","LU0979878070.USD","LU0072461881.USD","LU0856984785.SGD","LU1162221912.USD","LU0348735423.USD","LU2125154778.USD","LU0456827905.SGD","SG9999002463.SGD","LU0823426480.USD","LU0417516902.SGD","LU2456880835.USD","LU0326950275.SGD","LU2462157665.USD","BK4559","LU1794554557.SGD","BK4585","LU0051755006.USD","LU0572944931.SGD","LU2039709279.SGD","BK1610","IE00B0JY6N72.USD","LU0819121731.USD","LU0708995583.HKD","02269","BK4504","SG9999014674.SGD"],"gpt_icon":0},{"id":"2603612095","title":"WuXi XDC Cayman Launches Voluntary Cash Offer for All Outstanding Shares and Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612095","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603612095?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:57","pubTimestamp":1768402640,"startTime":"0","endTime":"0","summary":"Citigroup Global Markets Asia Limited, on behalf of the offeror, has launched voluntary conditional cash offers to acquire all issued shares of WuXi XDC Cayman Inc. that are not already owned or agreed to be acquired by the offeror and its concert parties, as well as to cancel all outstanding share options. WuXi Biologics, the controlling shareholder of the offeror, has provided written approval for the offers and the related transactions. A circular with further details and recommendations from the directors of the offeror is expected to be sent to WuXi XDC shareholders on or before February 4, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi XDC Cayman Inc. published the original content used to generate this news brief via ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDLzQq8c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","02268","BK4588","LU0052756011.USD","LU0106831901.USD","LU1794554557.SGD","LU0052750758.USD","BK4566","LU0456846285.SGD","LU0856984785.SGD","LU0588546209.SGD","LU0310800965.SGD","LU2488822045.USD","BK4207","SG9999002562.SGD","BK1589","LU0359202008.SGD","LU0417516738.SGD","IE00BSNM7G36.USD","LU0043850808.USD","LU0979878070.USD","LU0039217434.USD","LU1242518931.SGD","LU3063872942.SGD","02269","LU1880383366.USD","LU0348735423.USD","BK4534","BK4585","SG9999014674.SGD","BK1610","LU0819121731.USD","BK4559","LU0128525689.USD","LU0359201612.USD","LU0098860793.USD","LU0516422440.USD","BK1576","LU1366192091.USD","LU0348825331.USD","LU0170899867.USD","LU0516422952.EUR","LU1267930227.SGD","LU1791807156.HKD","SG9999002463.SGD","LU1242518857.USD","LU0516423174.USD","LU0823426308.USD","LU0320764599.SGD","LU0307460666.USD"],"gpt_icon":0},{"id":"2603612792","title":"TOT BIOPHARM Receives Voluntary Cash Offer for All Outstanding Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612792","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603612792?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:53","pubTimestamp":1768402399,"startTime":"0","endTime":"0","summary":"Citigroup Global Markets Asia Limited, on behalf of an offeror, has made voluntary conditional cash offers to acquire all issued shares of TOT BIOPHARM International Co. Ltd., excluding those already owned or agreed to be acquired by the offeror and its concert parties, and to cancel all outstanding share options. WuXi Biologics, as the controlling shareholder of the offeror, has provided written approval for the transaction. A circular with further details and recommendations from the directors of the offeror is expected to be distributed to shareholders on or before 4 February 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TOT BIOPHARM International Co. Ltd. published the original content used to generate this news brief via II","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL1D7WXl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572944931.SGD","BK1574","LU1242518857.USD","LU1880383366.USD","SG9999002562.SGD","LU0588546209.SGD","BK4534","LU1162221912.USD","LU0072461881.USD","BK1161","LU0516423091.SGD","BK4559","LU0310800965.SGD","01875","LU0039217434.USD","LU0417516738.SGD","LU1791807156.HKD","LU0098860793.USD","LU2417539215.USD","LU0326950275.SGD","LU1244550577.SGD","LU0979878070.USD","LU0320765646.SGD","BK1610","LU2360032135.SGD","LU0043850808.USD","IE00BSNM7G36.USD","LU0327786744.USD","BK1141","LU0051755006.USD","LU2236285917.USD","LU1242518931.SGD","LU0516422440.USD","LU3063872942.SGD","LU0708995583.HKD","LU0320764599.SGD","LU0052756011.USD","LU1688375341.USD","BK4566","BK4588","LU0128525689.USD","LU0477156953.USD","LU2039709279.SGD","LU0348825331.USD","02269","BK4504","LU0516422952.EUR","LU0348735423.USD","LU1244550494.USD","BK1521"],"gpt_icon":0},{"id":"2603127956","title":"WuXi XDC Cayman Expects Net Profit to Rise Over 38% for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2603127956","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603127956?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:51","pubTimestamp":1768402282,"startTime":"0","endTime":"0","summary":"WuXi XDC Cayman Inc. has announced that, based on preliminary unaudited management accounts for the year ended December 31, 2025, the group expects to record remarkable growth in key financial performance indicators. Notably, the company anticipates that both gross profit and adjusted financial measures will grow at rates significantly higher than revenue, reflecting enhanced operational efficiency and profitability. Net profit is expected to increase by more than 38% compared to the previous year, despite adverse impacts from foreign exchange and interest rate movements. Final annual results are yet to be finalized and are expected to be published on or about March 23, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi XDC Caym","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL8GpLxJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014674.SGD","LU1720050803.USD","LU0819121731.USD","LU3063872942.SGD","02268","BK1576","IE00B0JY6N72.USD","LU0348825331.USD","LU0516422440.USD","LU0456827905.SGD","LU0708995583.HKD","02269","LU0417516738.SGD","BK1589","BK1521","LU0307460666.USD","BK1610","LU0516423091.SGD","LU1242518931.SGD","SG9999002562.SGD","LU2039709279.SGD","LU0181495838.USD","LU0039217434.USD","LU0327786744.USD","LU0326950275.SGD","LU0823426480.USD","LU0823426308.USD","LU0052750758.USD","LU1688375341.USD","LU0051755006.USD","LU0043850808.USD","BK1141","LU2488822045.USD","SG9999002463.SGD","LU0588546209.SGD","LU0856984785.SGD","LU0359202008.SGD","LU0516423174.USD","LU0979878070.USD","LU1242518857.USD","LU1880383366.USD","LU0140636845.USD","LU0572944931.SGD","LU0320764599.SGD","LU0348735423.USD","LU0516422952.EUR","LU0456846285.SGD","LU0359201612.USD","LU0417516902.SGD","LU0516422366.SGD"],"gpt_icon":0},{"id":"2603692632","title":"Assessing WuXi Biologics (SEHK:2269) Valuation After PatroLab Launch And New UK MHRA GMP Certifications","url":"https://stock-news.laohu8.com/highlight/detail?id=2603692632","media":"Simply Wall St.","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603692632?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:28","pubTimestamp":1768314503,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) (SEHK:2269) is in focus after receiving UK MHRA GMP certifications for two Wuxi facilities and unveiling its PatroLabTM digital twin platform, developments that may reshape how investors view its outsourcing capabilities.\nSee our latest analysis for WuXi Biologics (Cayman).\nThe recent UK MHRA GMP certifications and the launch of PatroLabTM arrive while WuXi Biologics’ share price has climbed to HK$39.78, with a 1-year total shareholder return of 126.02% but negative...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/assessing-wuxi-biologics-sehk2269-valuation-after-patrolab-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/assessing-wuxi-biologics-sehk2269-valuation-after-patrolab-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1242518931.SGD","LU1688375341.USD","LU0823426480.USD","LU0417516738.SGD","LU1720050803.USD","LU0516423174.USD","LU0708995583.HKD","LU0456827905.SGD","LU0823426308.USD","LU0359202008.SGD","LU1880383366.USD","LU0348825331.USD","LU0572944931.SGD","LU0588546209.SGD","LU0417516902.SGD","LU1794554557.SGD","IE00B0JY6N72.USD","LU0327786744.USD","LU0039217434.USD","SG9999002562.SGD","LU0043850808.USD","LU0856984785.SGD","BK1610","LU0052750758.USD","LU0051755006.USD","LU0326950275.SGD","BK1141","LU0516422366.SGD","LU0979878070.USD","LU3063872942.SGD","02269","LU0516423091.SGD","LU0348735423.USD","LU0516422952.EUR","LU1242518857.USD","LU0307460666.USD","BK1589","LU2039709279.SGD","BK1521","LU0181495838.USD","LU0516422440.USD","LU0320764599.SGD","LU0456846285.SGD","LU0140636845.USD","LU0819121731.USD","BK1576","SG9999002463.SGD","LU0359201612.USD"],"gpt_icon":0},{"id":"1132249843","title":"Zhutong Hong Kong Stock Connect Active Trading | January 13","url":"https://stock-news.laohu8.com/highlight/detail?id=1132249843","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132249843?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:14","pubTimestamp":1768302845,"startTime":"0","endTime":"0","summary":"On January 13, 2026, Alibaba-W (09988), Tencent Holdings (00700), and Xiaomi Group-W (01810) ranked as the top three stocks by turnover value on the Shanghai-Hong Kong Stock Connect (Southbound),...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0107464264.USD","LU0417516571.SGD","02228","LU0117841782.USD","LU0164865239.USD","BK1558","LU0214875030.USD","LU2125910849.SGD","BK1523","LU0345769631.USD","LU0348827113.USD","HK0000252152.HKD","LU0463099449.HKD","LU0630378429.USD","LU0164872284.USD","BK4587","LU1522347837.USD","LU0011963245.USD","LU0251144936.SGD","LU0345769128.USD","LU0192582467.USD","BK1546","LU0359201885.HKD","LU2106854487.HKD","LU2476274308.USD","LU0634319403.HKD","LU0823038988.USD","LU1282648689.USD","LU0128522157.USD","LU0823426308.USD","BK4533","LU0607220059.USD","LU2237443622.USD","IE00B067MR52.USD","LU0210526637.USD","LU0821914370.USD","LU1880383440.USD","SGXZ81163826.USD","09995","LU0327786744.USD","LU0320764243.SGD","LU0096374516.USD","LU1808992512.USD","LU2023250504.SGD","LU1226288170.HKD","LU0593848301.USD","688331","LU2097828805.USD","LU0499858602.USD","HK0000320223.HKD","TCEHY","LU0328353924.USD","BK1161","LU1804176565.USD","LU1481107354.HKD","BK1531","IE00BMPRXR70.SGD","00883","METmain","LU0823397285.USD","LU0029875118.USD","LU1497734951.SGD","LU1051768304.USD","IE00B8HQ1Z84.USD","LU0235996351.USD","LU2039709279.SGD","LU0648000940.SGD","LU0878005551.USD","LU2237443382.USD","BK4588","SG9999001093.SGD","LU0348766576.USD","LU0516423174.USD","LU0828237940.HKD","LU1152091754.HKD","LU1044875133.USD","IE00BQXX3F31.USD","BK4543","LU0345776255.USD","LU0831093199.SGD","03690","BK1575","LU0786609619.USD","IE00BQXX3D17.EUR","LU0683595622.HKD","SG9999002463.SGD","BK1141","IE00B97KM107.HKD","LU1655091459.SGD","LU0577902298.EUR","LU1769817179.HKD","LU2449936058.SGD","LU0509642566.USD","SG9999014674.SGD","LU2152927971.USD","SG9999000327.SGD","LU1733274473.HKD","BK1528","LU0985320562.USD","HK0000352291.HKD","LU0310800965.SGD","LU2242644610.SGD","LU0531971595.HKD","BK1238","LU0431992006.USD","LU0738912210.USD","LU0072913022.USD","LU0577902538.SGD","SG9999001689.USD","LU1719994722.HKD","LU0561508036.HKD","LU1048484197.HKD","LU2237443978.SGD","LU1235295612.USD","LU0648948544.HKD","BK1617","LU0048580855.USD","LU0886674414.USD","LU1725190679.HKD","LU0106959298.USD","LU0797268264.HKD","02208","LU0762541174.USD","LU1497733631.SGD","BABA","LU1880398554.USD","IE00BZ08YS42.EUR","LU1224709979.USD","LU0502904849.HKD","SG9999001846.SGD","LU0054450605.USD","LU0067412154.USD","LU0871576103.HKD","LU1718418525.SGD","LU0128522744.USD","BK4503","LU2362540622.SGD","BK1513","BK4581","SG9999001226.SGD","LU1634259557.SGD","LU0672654166.SGD","LU1224444064.USD","LU0823413660.USD","LU1642822792.SGD","LU0072462343.USD","BK4526","LU0269904917.USD","LU2097828631.EUR","LU1023057109.AUD","LU0289960550.SGD","LU1044874839.SGD","IE00BQXX3C00.GBP","IE00B0169N27.USD","LU2357305700.SGD","LU1226287875.USD","SG9999001903.USD","LU1515016050.SGD","LU1720051108.HKD","LU1734074674.USD","SGXZ90724238.SGD","LU1769817096.USD","LU1003077747.HKD","LU0106259558.USD","SG9999017495.SGD","LU0039217434.USD","LU0516422366.SGD","LU0819123356.HKD","LU1883866441.USD","LU0588545490.SGD","BK4585","LU0541501648.USD","LU2265009873.SGD","MIUmain","LU0188438112.USD","LU1868837565.USD","IE0009570106.USD","LU0210533765.USD","IE00B3M56506.USD","LU1951186391.HKD","IE0032834883.USD","LU1439103000.SGD","LU0882747503.HKD","LU1242518857.USD","BK1584","LU0196878994.USD","SG9999001051.SGD","LU0261950983.USD","BK4579","BK4527","IE0008369823.USD","LU0633140727.USD","LU1235294995.USD","LU1282649067.USD","IE00B543WZ88.USD","BK4220","00981","LU0611395673.USD","LU0359202008.SGD","LU1064131003.USD","LU0890818403.SGD","LU1188198961.HKD","80883","600941","SG9999006597.SGD","LU1282649810.SGD","BK1586","LU0531970944.HKD","HBBD.SI","LU2362541513.USD","LU1960683339.HKD","01024","LU0143863198.USD","LU0543330483.HKD","LU0608807433.USD","LU1794554557.SGD","LU1115378108.SGD","SGXZ49509284.SGD","LU0169518387.USD","LU0197773673.USD","IE00B031HW06.USD","LU2087589342.USD","LU0862451837.USD","BK1516","SG9999002828.SGD","LU1226287529.USD","IE0001KFT4U8.USD","LU0456827905.SGD","LU0348805143.USD","HK0000252160.HKD","BK4534","LU0080751232.USD","LU1316542783.SGD","LU0828237510.HKD","LU0762542818.HKD","LU0823426480.USD","BK4575","BK1163","BK1615","LU0348735423.USD","LU0577902454.USD","LU0130103400.USD","LU0348788117.USD","LU1981816686.USD","BK4504","LU0210527791.USD","LU0949170772.SGD","LU0049112450.USD","LU2462611646.USD","LU2251237306.USD","LU0261947096.USD","BK1142","LU0106252389.USD","LU1196710195.USD","SG9999001069.SGD","LU2279701549.SGD","IE0008368742.USD","LU2293587155.HKD","HTCD.SI","BK4505","SG9999015986.USD","LU0229945570.USD","LU0165289439.USD","LU0737861699.HKD","LU0873338254.USD","LU0228659784.USD","LU1880383366.USD","LU2097829019.USD","HK0000914686.HKD","LU0588545730.USD","LU0370786039.SGD","LU0791590937.USD","LU0898667661.SGD","LU0345775950.USD","LU0831103253.SGD","BK1506","688981","LU1008478684.HKD","LU0737861772.HKD","LU0455707207.USD","BK1536","LU0441854154.USD","IE0003851619.USD","SGXZ99366536.SGD","LU0708995153.HKD","LU0047713382.USD","SG9999014880.SGD","LU2778985437.USD","LU0203345920.USD","LU0048597586.USD","LU2051468812.USD","LU2148611432.USD","LU1267930227.SGD","BK1502","BK1609","LU0348814723.USD","LU0326950275.SGD","LU1956131251.USD","LU1814569148.SGD","LU0132412106.USD","BK1589","LU0516422440.USD","KSTmain","BK1590","LU0384037296.USD","LU0203347892.USD","BK1594","BK4531","LU0469268626.HKD","LU1568876251.USD","LU0051755006.USD","LU0054237671.USD","LU0594300179.USD","SGXZ81514606.USD","LU0545039389.USD","BK1618","LU0231483743.USD","LU1785774172.SGD","LU0675040207.SGD","LU0417516738.SGD","09926","LU0588545904.SGD","LU0140636845.USD","GB00BDT5M118.USD","LU0819121731.USD","IE0032431581.USD","IE0008368411.USD","SGXZ31699556.SGD","SGXZ51526630.SGD","LU1282651048.USD","BK1517","LU1282649141.HKD","IE00BMPRXN33.USD","BK4548","LU0127658192.USD","SG9999000459.SGD","LU0049853897.USD","LU2237443549.SGD","600938","HXXD.SI","LU0070217475.USD","LU1048588211.SGD","IE0031814852.USD","LU0449509016.USD","IE00B031J352.USD","LU0211331839.USD","LU0708995583.HKD","LU0052756011.USD","LU0307460666.USD","LU0244354667.USD","LU1323998911.USD","LU0128525689.USD","LU2237443465.HKD","LU0651947912.USD","LU1733274390.USD","LU2125910500.SGD","IE0034224299.USD","BK1521","LU0553294199.USD","BK1095","LU0417516902.SGD","LU0228367735.SGD","LU1770034418.SGD","LU1439102457.SGD","IE00BZ08YT58.USD","LU1044876610.USD","IE00BZ08YR35.GBP","IE0008368304.USD","LU0264606111.USD","LU2097828474.EUR","LU2097828714.EUR","LU3063872942.SGD","LU0348816934.USD","LU0640798160.USD","LU2226246903.HKD","SG9999002562.SGD","BK4535","BK4538","LU0320764599.SGD","SG9999018865.SGD","BK4558","IE00B29SXG58.USD","LU0918141705.HKD","LU0348783233.USD","LU0572940350.SGD","LU0823413587.USD","LU2362541273.HKD","BK1205","LU1969619763.USD","LU0149534421.HKD","LU0130518102.USD","09988","LU0823041008.USD","SG9999015952.SGD","LU0061477393.USD","LU2237443895.HKD","00941","LU0700851271.USD","81810","BK4502","LU0173614495.USD","LU0642271901.SGD","LU0315179316.USD","LU1823568750.SGD","LU0577902611.USD","LU1634259391.SGD","LU1810669033.SGD","LU0543330566.HKD","LU2328871848.SGD","LU0477156797.USD","LU1105468828.SGD","HK0000306701.USD","LU1102505929.USD","00700","LU1629966141.USD","LU0540923850.HKD","SG9999007991.SGD","LU0501845795.SGD","LU1328277881.USD","BK1233","81024","LU0608807946.USD","LU1196710351.USD","BK1501","BK1610","LU0516423091.SGD","LU1366334578.USD","LU1720051017.SGD","IE00BPRC5H50.USD","LU0577902371.SGD","LU2177674079.SGD","LU0630378692.HKD","LU1770036033.HKD","LU1548497426.USD","HK0000165453.HKD","LU0651946864.USD","BK1193","BK1249","LU1226288253.USD","LU0329678337.USD","LU0348784397.USD","LU0348723411.USD","LU1568876335.HKD","LU0348783662.USD","LU0572939691.SGD","LU0163747925.USD","LU1282651121.HKD","LU2317271919.USD","LU0572944931.SGD","LU0456842615.SGD","SG9999013353.USD","HMTD.SI","BK1152","BK1526","02269","SG9999014914.USD","LU0181495838.USD","SG9999006514.SGD","LU1813983027.USD","LU0175139822.USD","LU1226288097.SGD","HK0000352382.USD","LU0143863784.USD","SG9999000418.SGD","BK4607","LU0633140560.USD","89988","BK1576","IE00BGV7N243.SGD","LU1102505762.USD","HK0000914660.USD","LU0880133367.SGD","LU2008162690.USD","LU0823040885.USD","LU1868838027.USD","LU0588546209.SGD","HK0000320264.USD","LU1366334651.USD","SG9999018857.SGD","IE00B0JY6N72.USD","LU0823039010.USD","IE0003895053.USD","LU0164880469.USD","LU2247934214.USD","LU0197773160.USD","BK1583","LU0868486357.SGD","LU0287142896.SGD","LU0823397103.USD","LU1211504680.USD","LU0516422952.EUR","LU1196710864.SGD","LU0348767384.USD","LU1251922891.USD","LU0979878070.USD","LU1720050803.USD","IE00BFMHRM44.USD","SG9999014906.USD","LU0251143458.SGD","BK4524","LU0293314216.USD","LU1152091168.USD","BK1591","LU1675838814.USD","LU0878004406.USD","LU1868837722.USD","LU1064130708.USD","LU0828238088.HKD","LU0865486749.SGD","LU2488822045.USD","002202","IE00B0169L03.USD","BK1574","LU0084288322.USD","IE00B8L5B284.USD","LU1226287792.SGD","LU0589944569.HKD","WXXWY","01810","LU0456846285.SGD","HK0000306685.HKD","LU1497733557.USD","MPNGY","SG9999015978.USD","IE0003795394.USD","LU0254981946.USD","BK0214","LU0314109678.HKD","SG9999014898.SGD","LU2097828557.USD","LU1504937902.USD","LU0414403682.SGD","LU0329678170.USD","BK1607","LU1831875114.USD","LU2498475776.HKD","LU1242518931.SGD","LU0396098781.USD","LU0650527681.SGD","LU0499858438.USD","LU1993786604.SGD","LU1201861165.SGD","LU0784639295.USD","LU2251237488.HKD","LU1046422090.SGD","LU1688375341.USD","XIACY","LU0488056044.USD","IE00BF5LJ272.USD","LU0211977185.USD","LU2476274720.SGD","LU0449515922.USD","BK4554","LU1328615791.USD","LU0359201612.USD","LU0762540952.USD","IE00B5MMRT66.SGD","BK4614","LU0348825331.USD","LU1046421795.USD","BK4565","LU1974910355.USD","LU2045819591.USD","BK1614","LU0738911758.USD","LU0856984785.SGD","LU0862451753.SGD","SG9999015945.SGD","LU0259732245.USD","LU2257852520.SGD","LU2148510915.USD","LU0326948709.USD","LU0791591158.USD","LU1807302812.USD","LU1051769294.HKD","LU0972618739.USD","LU0029874905.USD","LU0661504455.SGD","LU1917777945.USD","LU0043850808.USD","LU0594300419.USD","LU0149721374.USD","LU0117844026.USD","LU0918141887.USD","LU0048388663.USD","LU2399975544.HKD","LU0052750758.USD","SG9999003461.SGD","LU0320764755.SGD","LU0605514214.HKD","BK1608","BK1604","BK4122","BK1588","HK0000500386.USD","SG9999004220.SGD","LU1880398471.USD","LU1961090484.USD","LU0541502299.USD","LU1303224171.USD","LU1048596156.SGD","LU2133065610.SGD","LU0315178854.USD","IE00B031HY20.USD"],"gpt_icon":1},{"id":"2603035576","title":"WuXi Biologics Receives UK MHRA GMP Certification for Ophthalmic Biologic Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603035576","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603035576?lang=en_us&edition=fundamental","pubTime":"2026-01-13 11:07","pubTimestamp":1768273658,"startTime":"0","endTime":"0","summary":"WuXi Biologics  Inc. announced that its Drug Product Facility 5  and Drug Product Packaging Center  in Wuxi have received Good Manufacturing Practice  certifications from the UK Medicines and Healthcare products Regulatory Agency  for the commercial manufacturing of an ophthalmic biologic. The certification follows a four-day inspection with no critical findings. WuXi Biologics provides end-to-end manufacturing services for this product, covering both drug substance and drug product. As of the end of 2025, WuXi Biologics has passed 46 regulatory inspections and obtained 136 facility license approvals, maintaining a 100% pass rate for FDA Pre-License Inspections. The company operates 15 GMP-certified drug substance and drug product facilities within its global network.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpos","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL6swnST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU1242518857.USD","LU0348735423.USD","LU0140636845.USD","LU0823426308.USD","LU0456846285.SGD","LU0417516738.SGD","LU0051755006.USD","LU0181495838.USD","LU0043850808.USD","BK1141","LU2039709279.SGD","LU0039217434.USD","BK1576","LU0456827905.SGD","LU0516423091.SGD","LU0359201612.USD","LU0516422952.EUR","LU0819121731.USD","LU1688375341.USD","LU0327786744.USD","LU0359202008.SGD","LU0516423174.USD","LU0856984785.SGD","02269","BK1589","LU0348825331.USD","LU0307460666.USD","LU0572944931.SGD","BK1610","SG9999002562.SGD","LU1794554557.SGD","LU0516422440.USD","LU0417516902.SGD","LU3063872942.SGD","LU0708995583.HKD","LU1242518931.SGD","SG9999002463.SGD","LU1880383366.USD","LU1720050803.USD","LU0588546209.SGD","LU0320764599.SGD","LU0979878070.USD","LU0052750758.USD","LU0823426480.USD","IE00B0JY6N72.USD","BK1521","LU0516422366.SGD"],"gpt_icon":0},{"id":"1151630633","title":"Hong Kong Stocks Movement | CRO Concept Stocks Lead Gains with WUXI APPTEC (02359) Forecasting Doubled Net Profit; Sector Poised for \"Davis Double Play\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1151630633","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151630633?lang=en_us&edition=fundamental","pubTime":"2026-01-13 10:17","pubTimestamp":1768270672,"startTime":"0","endTime":"0","summary":"CRO concept stocks led the gains in the Hong Kong market. At the time of writing, WUXI APPTEC (02359) was up 8.48% at HKD 120.2; ASYMCHEM (06821) rose 7.4% to HKD 91.4; PHARMARON (03759) increased...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880383366.USD","LU1046422090.SGD","BK1141","603259","LU0039217434.USD","LU1979443071.USD","SG9999002562.SGD","LU0348825331.USD","LU0708995583.HKD","LU0326950275.SGD","LU0456842615.SGD","LU0588546209.SGD","LU2328871848.SGD","SG9999002463.SGD","LU0140636845.USD","LU0456827905.SGD","LU1242518857.USD","LU0348735423.USD","03347","LU0052750758.USD","LU1794554557.SGD","LU1808992512.USD","BK0216","BK1610","BK1583","LU0043850808.USD","02359","IE00B0JY6N72.USD","LU0417516902.SGD","LU0516423174.USD","LU1720050803.USD","LU2039709279.SGD","LU1242518931.SGD","LU1934453819.USD","BK1521","BK1191","LU2488822045.USD","LU0823426308.USD","BK1589","LU0516422952.EUR","LU1688375341.USD","03759","LU0572944931.SGD","06821","LU2125910500.SGD","LU0359202008.SGD","LU1997245177.USD","LU1997245094.SGD","LU0417516738.SGD","LU0320764599.SGD","LU3063872942.SGD","LU0181495838.USD","LU0456846285.SGD","LU0516422440.USD","LU2045819591.USD","LU0819121731.USD","BK1576","LU0307460666.USD","LU0979878070.USD","LU0823426480.USD","LU0516423091.SGD","LU2242644610.SGD","02269","LU0327786744.USD","LU2495084118.USD","LU1997244956.HKD","LU0516422366.SGD","LU0856984785.SGD","LU0051755006.USD","LU1969619763.USD","LU0359201612.USD"],"gpt_icon":0},{"id":"2602592790","title":"Wuxi Biologics (Cayman) Stock Rallies 1.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2602592790","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602592790?lang=en_us&edition=fundamental","pubTime":"2026-01-12 16:33","pubTimestamp":1768206780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 1.4% to 37.58 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.4% to 26608.48.This was the stock's seventh consecutive day of gains.Wuxi Biologics  Inc. closed 12% short of its 52-week high of HK$42.60, which the company achieved Oct. 3.Trading volume totaled 54.7 million shares, compared to the 50-day average of 29.8 million shares.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002463.SGD","LU0417516902.SGD","LU0181495838.USD","LU0140636845.USD","LU0516422440.USD","LU0516422952.EUR","SG9999002562.SGD","LU0052750758.USD","LU0043850808.USD","LU1688375341.USD","BK1589","LU0588546209.SGD","LU0456846285.SGD","LU0348825331.USD","LU1794554557.SGD","LU0359201612.USD","BK1521","LU0516423174.USD","LU2039709279.SGD","LU0359202008.SGD","LU0572944931.SGD","LU0307460666.USD","BK1576","BK1610","LU0348735423.USD","LU1242518931.SGD","LU0417516738.SGD","LU0823426480.USD","LU0326950275.SGD","LU0856984785.SGD","LU1880383366.USD","LU0327786744.USD","BK1141","LU1242518857.USD","LU0039217434.USD","LU0979878070.USD","LU1720050803.USD","02269","LU3063872942.SGD","LU0819121731.USD","LU0320764599.SGD","LU0516423091.SGD","LU0823426308.USD","IE00B0JY6N72.USD","LU0051755006.USD","LU0708995583.HKD","LU0516422366.SGD","LU0456827905.SGD"],"gpt_icon":0},{"id":"1187399747","title":"WUXI BIO (02269): Total Integrated Projects Reach Record High of 945 in 2025, Bispecific/Multispecific Antibody Revenue More Than Doubles","url":"https://stock-news.laohu8.com/highlight/detail?id=1187399747","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187399747?lang=en_us&edition=fundamental","pubTime":"2026-01-12 15:51","pubTimestamp":1768204291,"startTime":"0","endTime":"0","summary":"Materials from a keynote speech delivered by WUXI BIO (02269) CEO Chen Zhisheng at the 44th J.P. Morgan Healthcare Conference revealed that the group's business maintained rapid growth in 2025. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880383366.USD","SG9999002463.SGD","SG9999002562.SGD","LU0572944931.SGD","LU1794554557.SGD","LU0181495838.USD","BK1610","LU0039217434.USD","LU0823426308.USD","LU0516423174.USD","LU0327786744.USD","LU0140636845.USD","02269","LU0819121731.USD","LU0359202008.SGD","LU0348735423.USD","LU0823426480.USD","BK1576","LU0043850808.USD","LU0359201612.USD","LU0456827905.SGD","LU0856984785.SGD","LU0516422366.SGD","BK1521","LU1242518857.USD","LU0052750758.USD","LU3063872942.SGD","BK1589","LU0516422440.USD","LU0417516902.SGD","LU0348825331.USD","LU0417516738.SGD","LU1242518931.SGD","IE00B0JY6N72.USD","LU1688375341.USD","LU0456846285.SGD","LU0051755006.USD","LU0979878070.USD","LU0320764599.SGD","LU0516422952.EUR","LU2039709279.SGD","LU0307460666.USD","LU0588546209.SGD","LU0516423091.SGD","BK1141","LU0708995583.HKD","LU1720050803.USD","LU0326950275.SGD"],"gpt_icon":0},{"id":"1166114367","title":"Market Insights: Focus on TSMC Earnings This Week; Commercial Space Emerges as Strongest Theme","url":"https://stock-news.laohu8.com/highlight/detail?id=1166114367","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166114367?lang=en_us&edition=fundamental","pubTime":"2026-01-12 09:15","pubTimestamp":1768180532,"startTime":"0","endTime":"0","summary":"The A-share market is currently exceptionally strong, with the Shanghai Composite Index breaking through the 4100-point level last Friday and trading volume exceeding three trillion yuan, marking a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e2a27470ec0171f279c35a89d51f30dc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSM","LU2271345857.HKD","LU0856984785.SGD","BK4543","LU0051755006.USD","LU0456846285.SGD","LU1211504680.USD","BK4605","LU1282649067.USD","LU0417516902.SGD","LU1868837565.USD","LU2471134523.USD","LU0316494557.USD","LU0348735423.USD","LU0353189680.USD","BK4585","LU1712237335.SGD","BK4612","LU0082616367.USD","BK4505","LU2106854487.HKD","LU0181495838.USD","LU2237443978.SGD","LU1720050803.USD","LU0124676726.USD","LU0198837287.USD","IE00BFXG0V08.USD","LU2750360641.GBP","LU1242518857.USD","IE0004445239.USD","LU2063271972.USD","BK4503","LU0488056044.USD","LU0516423091.SGD","LU0516423174.USD","LU1880383366.USD","LU1023057109.AUD","LU0979878070.USD","LU0823421333.USD","LU2092937221.SGD","LU2249611893.SGD","BK4581","LU0689626769.HKD","LU1508157978.USD","LU2125154935.USD","LU2294711713.HKD","LU0353189763.USD","LU0541502299.USD","LU1046422090.SGD","LU2133065610.SGD","WXXWY","LU2054465674.USD","LU1242518931.SGD","LU2860962120.EUR","BK4527","LU0642271901.SGD","LU0158827948.USD","LU0323591593.USD","LU0143863784.USD","LU1868838027.USD","IE00B5TLWC47.USD","IE00BQXX3C00.GBP","BK1587","LU2471134879.HKD","LU0109392836.USD","LU0823426308.USD","LU2087625088.SGD","LU0359202008.SGD","LU0823414478.USD","LU1037948897.HKD","LU1974910355.USD","LU0140636845.USD","LU2491049909.HKD","LU1868837722.USD","LU0158827781.USD","LU0326950275.SGD","LU0572944931.SGD","LU2237443622.USD","LU0307460666.USD","LU2041044095.USD","LU0359201612.USD","LU0320764599.SGD","LU2471134952.CNY","LU1989764664.SGD","LU2458330243.SGD","LU2543165471.USD","LU1623119135.USD","LU0238689110.USD","BK4512","LU2491050154.USD","LU2750360997.AUD","LU0516422952.EUR","LU0719512351.SGD","SG9999004220.SGD","LU2211814178.USD","SGXZ99366536.SGD","SG9999002463.SGD","LU0049112450.USD","IE00B3M56506.USD","LU2458330169.SGD","LU2250418816.HKD","LU2237443382.USD","LU0965509010.AUD","LU0516422440.USD","LU1235295612.USD","LU0889565833.HKD","03145","LU2663582299.SGD","LU0861579265.USD","LU1934455194.USD","LU0708995583.HKD","LU1917777945.USD","LU0965509283.SGD","LU1316542783.SGD","LU0359201885.HKD","IE00BD6J9T35.USD","LU0588546209.SGD","IE00BQXX3D17.EUR","BK4532","LU0175139822.USD","LU0572940350.SGD","LU1794554557.SGD","SGXZ81514606.USD","LU2125154778.USD","IE0004091025.USD","LU0456827905.SGD","LU0792757196.USD","IE00BYQQ9H92.USD","LU0289960550.SGD","LU2360032135.SGD","LU0965508806.USD","SG9999002562.SGD","LU2089284900.SGD","LU0823414551.USD","LU2023250504.SGD","LU0541501648.USD","LU0823421416.USD","LU0052750758.USD","LU2211815571.USD","LU1803068979.SGD","LU2028103732.USD","BK1576","LU2357125470.USD","LU0965509101.SGD","LU2111349929.HKD","LU2360106780.USD","BK1189","BK4591","LU0572939691.SGD","LU0327786744.USD","LU1989764748.USD","BK4548","BK4534","LU2237443549.SGD","BK4588","LU1934455277.USD","LU0143863198.USD","IE0004086264.USD","LU0043850808.USD","BK4602","LU0094547139.USD","LU0384037296.USD","LU0889566641.SGD","LU1934455863.HKD","BK4533","IE00BKPKM429.USD","LU1267930813.SGD","BK4526","BK1219","LU1989772840.SGD","SGXZ51526630.SGD","LU0348825331.USD","LU0878005551.USD","LU0417516738.SGD","LU0056508442.USD","LU1282649810.SGD","LU2023251221.USD","BK1589","BK4550","LU0878004406.USD","LU0264606111.USD","LU0819121731.USD","LU0516422366.SGD","LU2506951792.HKD","BK1141","LU0348723411.USD","LU2089283258.USD","BK1610","LU0882747503.HKD","SG9999000418.SGD","LU1688375341.USD","LU2360108059.USD","BK1521","IE00BQXX3F31.USD","LU0039217434.USD","LU0823426480.USD","LU1037948541.HKD","LU2491050071.SGD","BK4554","BK4141","IE00BZ199S13.USD","02269","LU2039709279.SGD","IE00B0JY6N72.USD","IE00BHPRN162.USD","LU2298321311.HKD","LU1989772923.USD","LU1852331112.SGD","LU2247934214.USD","LU3063872942.SGD","LU2471134796.USD"],"gpt_icon":1},{"id":"2602559599","title":"Wuxi Biologics Unveils Scaled Global CRDMO Platform Advancing Biologics Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2602559599","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602559599?lang=en_us&edition=fundamental","pubTime":"2026-01-11 20:52","pubTimestamp":1768135968,"startTime":"0","endTime":"0","summary":"Wuxi Biologics  Inc. has released a presentation outlining its scaled CRDMO  platform, which supports the global advancement of biologics. The presentation details the company’s comprehensive end-to-end offerings across the biologics lifecycle, including services in monoclonal antibodies, bispecific antibodies, Fc-fusion proteins, antibody drug conjugates, viral vaccines, oncolytic viruses, virus-like particles, recombinant proteins, and antibody fragments. Key highlights include support for over 600 IND submissions globally, 25 commercial programs, and 74 Phase III projects. The company reports maintaining high reliability metrics, with a 98.3% DS success rate and a 99.6% DP success rate, and a 100% success rate in regulatory inspections by the FDA, EMA, and NMPA. Wuxi Biologics emphasizes its flexible service model, enabling global clients to access tailored contract services across research, development, and manufacturing. You can access the full presentation through the link below.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nNDL4tjbN4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002463.SGD","LU0417516902.SGD","LU0181495838.USD","LU0140636845.USD","LU0516422440.USD","LU0516422952.EUR","SG9999002562.SGD","LU0052750758.USD","LU0043850808.USD","LU1688375341.USD","BK1589","LU0588546209.SGD","LU0456846285.SGD","LU0348825331.USD","LU1794554557.SGD","LU0359201612.USD","BK1521","LU0516423174.USD","LU2039709279.SGD","LU0359202008.SGD","LU0572944931.SGD","LU0307460666.USD","BK1576","BK1610","LU0348735423.USD","LU1242518931.SGD","LU0417516738.SGD","LU0823426480.USD","LU0326950275.SGD","LU0856984785.SGD","LU1880383366.USD","LU0327786744.USD","BK1141","LU1242518857.USD","LU0039217434.USD","LU0979878070.USD","LU1720050803.USD","02269","LU3063872942.SGD","LU0819121731.USD","LU0320764599.SGD","LU0516423091.SGD","LU0823426308.USD","IE00B0JY6N72.USD","LU0051755006.USD","LU0708995583.HKD","LU0516422366.SGD","LU0456827905.SGD"],"gpt_icon":0},{"id":"2602568371","title":"Akari Therapeutics Highlights 2025 Progress and Plans Clinical Transition in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568371","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568371?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:00","pubTimestamp":1767967216,"startTime":"0","endTime":"0","summary":"Akari Therapeutics plc announced a business update highlighting progress made in 2025 and outlined its path toward becoming a clinical-stage oncology company in 2026. The company is advancing its proprietary PH1 spliceosome-modulating payload for antibody-drug conjugates , designed to deliver both direct tumor cell cytotoxicity and immune activation. In 2025, Akari established a strategic manufacturing partnership with WuXi Biologics and initiated Chemistry, Manufacturing and Controls  and other pre-filing activities to support clinical readiness. The company plans to start its first-in-human clinical trial as early as the end of 2026. Akari’s lead candidate, AKTX-101, targets the Trop2 receptor on cancer cells and has demonstrated significant activity and prolonged survival in preclinical studies, both as a single agent and in combination with checkpoint inhibitors. IND enabling studies for AKTX-101 are underway, and Akari is also advancing AKTX-102, an ADC targeting a novel antigen r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL837lln:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0327786744.USD","LU0516422440.USD","SG9999002562.SGD","LU0516423091.SGD","BK4139","LU2095319765.USD","LU0572944931.SGD","BK4007","LU0588546209.SGD","BK4588","LU0456827905.SGD","LU2039709279.SGD","LU0043850808.USD","NDAQ","LU0051755006.USD","LU0140636845.USD","LU0823426308.USD","LU0181495838.USD","LU3063872942.SGD","SG9999014021.USD","BK4112","LU1794554557.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","LU0516422952.EUR","BK1589","LU1880383366.USD","AKTX","SG9999002463.SGD","BK4585","LU0039217434.USD","BK1576","LU0823426480.USD","IE00B64PRP62.GBP","LU0320764599.SGD","IE00B3QW5Z07.USD","LU0348825331.USD","LU0856984785.SGD","LU0417516738.SGD","LU0417516902.SGD","LU1720050803.USD","LU2210150020.SGD","LU0326950275.SGD","LU0456846285.SGD","02269","LU0348735423.USD","BK1610","LU0359201612.USD","IE00BKPKM429.USD","SG9999014039.USD"],"gpt_icon":0},{"id":"2602632233","title":"BRIEF-BlackRock's Long Position In WuXi Biologics Decreases To 5.61% On Jan 5 From 6.14% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2602632233","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602632233?lang=en_us&edition=fundamental","pubTime":"2026-01-09 18:33","pubTimestamp":1767954823,"startTime":"0","endTime":"0","summary":"BRIEF-BlackRock's Long Position In WuXi Biologics Decreases To 5.61% On Jan 5 From 6.14% - HKEXJan 9 (Reuters) - HKEX:BLACKROCK'S LONG POSITION IN WUXI BIOLOGICS 2269.HK DECREASES TO 5.61% ON JAN 5 FROM 6.14%Further company coverage: 2269.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA03P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","02269","LU0052750758.USD","LU1880383366.USD","LU0456827905.SGD","LU0307460666.USD","LU0588546209.SGD","LU0348825331.USD","SG9999002562.SGD","LU0417516738.SGD","LU0359201612.USD","LU0979878070.USD","SG9999002463.SGD","LU0326950275.SGD","LU0516422366.SGD","LU3063872942.SGD","LU0856984785.SGD","BK1576","LU0043850808.USD","LU1688375341.USD","LU0140636845.USD","LU0823426308.USD","BK1610","LU0516423091.SGD","LU1242518931.SGD","BK1589","BK1521","IE00B0JY6N72.USD","LU0327786744.USD","LU0572944931.SGD","LU0456846285.SGD","LU1242518857.USD","LU0417516902.SGD","LU0708995583.HKD","LU0516422952.EUR","LU2039709279.SGD","LU0359202008.SGD","LU0516422440.USD","LU0039217434.USD","LU0819121731.USD","LU0181495838.USD","LU0348735423.USD","LU1794554557.SGD","BK1141","LU0823426480.USD","LU0051755006.USD","LU0516423174.USD","LU1720050803.USD"],"gpt_icon":0},{"id":"2602662329","title":"BlackRock's Long Position in WuXi Biologics  Decreases to 5.61% on Jan 5 From 6.14% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2602662329","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602662329?lang=en_us&edition=fundamental","pubTime":"2026-01-09 17:27","pubTimestamp":1767950834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA03P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B0JY6N72.USD","LU1794554557.SGD","LU0359201612.USD","LU0320764599.SGD","LU0043850808.USD","LU0823426480.USD","BK1610","LU0348825331.USD","LU0051755006.USD","LU0348735423.USD","LU0359202008.SGD","LU0708995583.HKD","LU0823426308.USD","LU0856984785.SGD","LU0572944931.SGD","LU0516422952.EUR","SG9999002562.SGD","02269","LU1242518931.SGD","LU0588546209.SGD","LU0052750758.USD","LU0516423174.USD","LU1242518857.USD","LU1688375341.USD","LU2039709279.SGD","LU0417516738.SGD","LU3063872942.SGD","LU0327786744.USD","LU0140636845.USD","LU0516423091.SGD","LU0417516902.SGD","LU0979878070.USD","LU0516422366.SGD","LU0456846285.SGD","LU0456827905.SGD","LU1880383366.USD","LU0181495838.USD","BK1521","BK1141","BK1589","LU0039217434.USD","SG9999002463.SGD","LU0326950275.SGD","BK1576","LU0307460666.USD","LU0819121731.USD","LU1720050803.USD","LU0516422440.USD"],"gpt_icon":0},{"id":"2602891325","title":"Wuxi Biologics (Cayman) Stock Rises 1.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2602891325","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602891325?lang=en_us&edition=fundamental","pubTime":"2026-01-09 16:33","pubTimestamp":1767947580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 1.7% to 37.06 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.3% to 26231.79.This was the stock's sixth consecutive day of gains.Wuxi Biologics  Inc. closed 13% below its 52-week high of HK$42.60, which the company reached Oct. 3.Trading volume totaled 36.1 million shares, compared to the 50-day average of 30.0 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","LU0051755006.USD","LU0516423174.USD","SG9999002463.SGD","LU0327786744.USD","LU0979878070.USD","LU0456827905.SGD","LU0516422440.USD","BK1576","LU1242518857.USD","LU1720050803.USD","BK1589","LU0348825331.USD","LU0348735423.USD","LU0823426480.USD","LU0052750758.USD","LU0320764599.SGD","LU0456846285.SGD","BK1141","LU0588546209.SGD","IE00B0JY6N72.USD","02269","LU0417516902.SGD","LU3063872942.SGD","LU0359202008.SGD","LU0823426308.USD","LU1688375341.USD","LU0039217434.USD","LU0417516738.SGD","LU1794554557.SGD","BK1521","LU0043850808.USD","LU0572944931.SGD","LU1242518931.SGD","LU0140636845.USD","LU0708995583.HKD","SG9999002562.SGD","LU0307460666.USD","LU1880383366.USD","LU0326950275.SGD","LU0516422952.EUR","LU0856984785.SGD","LU0516422366.SGD","LU0819121731.USD","LU0181495838.USD","LU0516423091.SGD","BK1610","LU0359201612.USD"],"gpt_icon":0},{"id":"2601191362","title":"Whitehawk Therapeutics Unveils ADC Pipeline and Platform Innovations in Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2601191362","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601191362?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:33","pubTimestamp":1767879193,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Inc. has released a corporate presentation detailing its differentiated antibody-drug conjugate  platform, which features three ADC assets licensed from WuXi Biologics and novel linker-payload technology from Hangzhou DAC. The company highlights the use of a proprietary topoisomerase 1  inhibitor with an optimized DAR6 configuration, carbon bridge cleavable linker, and Fc-attenuated antibodies to enhance tumor targeting and minimize toxicity. Preclinical data indicate that the Whitehawk ADC platform demonstrates increased potency, improved stability, and a higher safety margin compared to average TOP1 inhibitor ADCs, with 3-10 times greater potency, 5-25 times more stability, and a 2-3 times higher safety margin in animal models. The portfolio includes three main assets: HWK-007 targeting PTK7 for a range of solid tumors, HWK-016 targeting MUC16 with an IND submitted, and HWK-206 targeting SEZ6 in neuroendocrine and CNS tumors, with anticipated clinical developme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL5lK8XN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","LU0516422952.EUR","LU1688375341.USD","LU0516422440.USD","LU0043850808.USD","BK1576","LU0516423091.SGD","LU0856984785.SGD","LU0327786744.USD","LU0979878070.USD","LU1242518931.SGD","WHWK","LU0708995583.HKD","LU0181495838.USD","LU0516422366.SGD","LU0456827905.SGD","LU0823426308.USD","LU0819121731.USD","LU1720050803.USD","LU2039709279.SGD","LU0307460666.USD","LU0417516738.SGD","IE00B0JY6N72.USD","LU0320764599.SGD","LU0326950275.SGD","LU0572944931.SGD","BK1141","LU0140636845.USD","BK1589","BK1610","LU1880383366.USD","LU0823426480.USD","BK1521","LU0359202008.SGD","LU0039217434.USD","LU0348735423.USD","BK4139","LU0051755006.USD","LU0588546209.SGD","LU0052750758.USD","LU1794554557.SGD","SG9999002463.SGD","LU3063872942.SGD","LU0456846285.SGD","02269","LU0359201612.USD","LU0516423174.USD","LU0348825331.USD","SG9999002562.SGD","LU1242518857.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0982},{"period":"1month","weight":0.2483},{"period":"3month","weight":0.1382},{"period":"6month","weight":0.4018},{"period":"1year","weight":1.2974},{"period":"ytd","weight":0.2729}],"compareEarnings":[{"period":"1week","weight":0.0296},{"period":"1month","weight":0.0669},{"period":"3month","weight":0.0664},{"period":"6month","weight":0.0845},{"period":"1year","weight":0.396},{"period":"ytd","weight":0.0505}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.063541},{"month":2,"riseRate":0.5,"avgChangeRate":-0.003108},{"month":3,"riseRate":0.625,"avgChangeRate":0.020153},{"month":4,"riseRate":0.375,"avgChangeRate":-0.000625},{"month":5,"riseRate":0.5,"avgChangeRate":0.00166},{"month":6,"riseRate":0.625,"avgChangeRate":0.064583},{"month":7,"riseRate":0.666667,"avgChangeRate":0.081469},{"month":8,"riseRate":0.555556,"avgChangeRate":0.030253},{"month":9,"riseRate":0.666667,"avgChangeRate":0.056337},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.033632},{"month":11,"riseRate":0.444444,"avgChangeRate":0.025584},{"month":12,"riseRate":0.555556,"avgChangeRate":0.009161}],"exchange":"SEHK","name":"WUXI BIO","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"WUXI BIO,02269,WUXI BIO股票,WUXI BIO股票老虎,WUXI BIO股票老虎国际,WUXI BIO行情,WUXI BIO股票行情,WUXI BIO股价,WUXI BIO股市,WUXI BIO股票价格,WUXI BIO股票交易,WUXI BIO股票购买,WUXI BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}